C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media

More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)

Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
09/2006
09/06/2006	CN1829732A Imageable animal model of SARS infection
09/06/2006	CN1829524A Anti-HIV-1 compounds based upon a conserved amino acid sequence shared by GP160 and the human CD4 protein
09/05/2006	US7101850 WISP polypeptides and nucleic acids encoding same
08/2006
08/31/2006	WO2005010163A3 Compositions and methods for immunotherapy of human immunotherapy of human immunodeficiency virus (hiv)
08/31/2006	WO2005003308A3 Biological data set comparison method
08/31/2006	WO2004094623A3 Cell adhesion and extracellular matrix proteins
08/31/2006	US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy
08/31/2006	US20060194318 Cultured cd14+ antigen presenting cells
08/31/2006	US20060194315 Compositions and methods for the control, differentiaton and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
08/30/2006	EP1694866A2 Gene expression profiles and methods of use
08/30/2006	EP1694863A2 Chromosome 5 genetic variants related to dyslexia
08/30/2006	EP1694861A2 Nucleic acid probes, broad-range primers, and methods in which they are used
08/30/2006	EP1694823A2 Compositions and methods of use for a fibroblast growth factor
08/30/2006	EP1694816A2 Biomarkers for alzheimer s disease
08/30/2006	EP1694815A2 Method and antisense compound for potentiating anti-cancer agents
08/30/2006	EP1694622A2 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof
08/30/2006	EP1694351A2 Glycopegylated follicle stimulating hormone
08/30/2006	EP1644502A4 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize
08/30/2006	EP1546383A4 Isolation of genetic molecules from a complex biological construct for use in genetic expression analysis
08/30/2006	CN1826414A Mutant adeno-associated virus virions and methods of use thereof
08/30/2006	CN1826408A Large volume ex vivo electroporation method
08/30/2006	CN1826350A Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
08/24/2006	WO2005059105A3 Cdk5 genetic markers associated with galantamine response
08/24/2006	WO2005023985A3 Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
08/24/2006	WO2005010148A3 Marks as modifiers of the pten pathway and methods of use
08/24/2006	WO2005001036A8 Novel trichoderma genes
08/24/2006	WO2005001031A3 Modulation of the rna interference pathway
08/24/2006	WO2004106491A3 Angiogenin-based hiv-1 therapies
08/24/2006	WO2004033641A3 Gene expression profiling of bladder cancer
08/24/2006	US20060191036 Growing a tobacco plant having cells that contain an exogenous DNA sequence that encodes quinolate phosphoribosyl transferase functional in the cells
08/24/2006	US20060191035 Methods and compositions for protein production in tobacco plants with reduced nicotine
08/24/2006	US20060191034 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor
08/24/2006	US20060189520 Treatment of diabetes
08/24/2006	US20060188975 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
08/24/2006	US20060188889 Use of differentially expressed nucleic acid sequences as biomarkers for cancer
08/24/2006	US20060188512 Active immunization to generate antibodies to solble a-beta
08/24/2006	US20060188440 Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer
08/23/2006	EP1692279A2 Preservative-containing virus formulations
08/23/2006	EP1692267A2 Methods of organ regeneration
08/23/2006	EP1692266A2 Improved methods for detecting and measuring specific nucleic acid sequences
08/23/2006	EP1692265A2 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
08/23/2006	EP1692264A2 Quantitative multiplex methylation-specific pcr
08/23/2006	EP1692263A2 Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
08/23/2006	EP1692262A2 METHOD OF DESIGNING siRNAS FOR GENE SILENCING
08/23/2006	EP1692260A2 Hypoxia - responsive human cngh-0002 genes and polypeptides
08/23/2006	EP1692258A2 Real time electronic cell sensing systems and applications for cell-based assays
08/23/2006	EP1692175A2 Compositions and methods for regulation of tumor necrosis factor-alpha
08/23/2006	EP1692161A2 Chimeric chemokine receptor polypeptides
08/23/2006	EP1691792A2 Compositions and methods for in vitro sorting of molecular and cellular libraries
08/23/2006	EP1691743A2 Regulation of cell membrane-mediated effects
08/23/2006	EP1691615A2 Orally-administered live bacterial vaccines for plague
08/23/2006	EP1620561A4 A delta-12 desaturase gene suitable for altering levels of polyun saturated fatty acids in oleaginous yeasts
08/23/2006	EP1461456A4 Methods for the identification of genetic features for complex genetics classifiers
08/23/2006	CN1823168A Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
08/22/2006	US7094572 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
08/17/2006	WO2006084953A1 Novel microbial enzymes and their use
08/17/2006	WO2005056768A3 Methods of designing, synthesizing, and propagating reference nucleic acids
08/17/2006	WO2005056754A3 Compositions and methods to reduce mutagenesis
08/17/2006	WO2005021713A3 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
08/17/2006	US20060183944 Process for preparing reverse transcriptase inhibitors
08/17/2006	US20060183895 Materials and methods for the modification of plant lignin content
08/17/2006	US20060183731 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
08/17/2006	US20060183123 Polymerase-based protocols for the introduction of combinatorial deletions...
08/17/2006	US20060182736 Transducible dna-binding proteins
08/17/2006	CA2597462A1 Novel microbial enzymes and their use
08/16/2006	EP1690935A2 Generation of xenogeneic antibodies
08/16/2006	EP1690934A2 Generation of xenogeneic antibodies
08/16/2006	EP1689887A2 Methods for quantitative determination of methylation density in a dna locus
08/16/2006	EP1689865A2 A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto
08/16/2006	EP1689854A2 Placental stem cells and uses thereof
08/16/2006	EP1689852A2 Compositions and methods to reduce mutagenesis
08/16/2006	EP1689851A2 Modified polypeptides with therapeutic activity and methods of use
08/16/2006	EP1689850A2 Inhibition of retroviral replication through modulation of the host cell ubiquitylation
08/16/2006	EP1689849A2 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
08/16/2006	EP1689848A2 Kahalalide-producing bacteria
08/16/2006	EP1689779A2 Native immunoglobulin binding reagents and methods for making and using same
08/16/2006	EP1689447A2 Gene transfer for regulating smooth muscle tone
08/16/2006	EP1689430A2 Tyrosinase mutant and methods of use thereof
08/16/2006	EP1627081A4 Use of jag2 expression in diagnosis of plasma cell disorders
08/16/2006	EP1623222A4 Ranbp2 as modifier of the pten/igf pathway and methods of use
08/16/2006	EP1567672A4 Expression profiling based on histocultures
08/16/2006	EP1543154A4 Abasic site endonuclease assay
08/10/2006	WO2005029280A3 Performing sequence analysis as a multipart plan storing intermediate results as a relation
08/10/2006	WO2005017101A3 Avian adenoassociated virus (aaav) and uses thereof
08/10/2006	WO2004096979A3 Methods and systems for annotating biomolecular sequences
08/10/2006	US20060179507 Nucleic acid encoding protein of given sequence; hydroxylation of taxoid; used in production of anti-cancer drugs paclitaxel and taxol
08/10/2006	US20060179492 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating
08/10/2006	US20060178330 Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1
08/10/2006	US20060177903 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
08/10/2006	US20060177900 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
08/10/2006	US20060177829 Contacting human beta-transducin repeat containing protein ( beta -TrCP) beta -TrCP1 or beta -TrCP2 with test compound and a phosphorylated cell division cycle 25A (Cdc25A) protein or a phosphorylated fragment thereof; detecting reduced binding compared to control; drug screening; anticarcinogenic agents
08/10/2006	US20060177825 Global analysis of transposable elements as molecular markers of the developmental potential of stem cells
08/09/2006	EP1688480A2 NOVEL ACETOACETYL-CoA REDUCTASE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL
08/09/2006	EP1687632A2 Plks as modifiers of the beta catenin pathway and methods of use
08/09/2006	EP1687450A2 Real-time detection of nucleic acids and proteins
08/09/2006	EP1687445A2 Polymeric nucleic acid hybridization probes
08/09/2006	EP1687422A2 Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid
08/09/2006	EP1687421A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
08/09/2006	EP1687406A2 Nucleic acid detection method having increased sensitivity
08/09/2006	EP1687405A2 Ttbks as modifiers of the beta catenin pathway and methods of use

1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 100